Research graph
References from Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids. Local targets link to admitted publications; unresolved targets remain external evidence.
Recent Advances in Neuroblastoma
10.1056/nejmra0804577 · 2010 · External reference
Neuroblastoma
10.1038/nrdp.2016.78 · 2016 · External reference
Anti‐GD2 Antibody With GM‐CSF, Interleukin‐2, and Isotretinoin for Neuroblastoma
10.1056/nejmoa0911123 · 2010 · External reference
Modeling Physiological Events in 2D vs. 3D Cell Culture
2017 · External reference
Three‐Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell‐Based Biosensors
10.1089/adt.2014.573 · 2014 · External reference
Multicellular Tumor Spheroids: An Underestimated Tool Is Catching up Again
10.1016/j.jbiotec.2010.01.012 · 2010 · External reference
Patient‐Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
10.1016/j.stem.2019.10.010 · 2020 · External reference
Newly‐Derived Neuroblastoma Cell Lines Propagated in Serum‐Free Media Recapitulate the Genotype and Phenotype of Primary Neuroblastoma Tumours
10.1016/j.ejca.2013.11.015 · 2014 · External reference
Patient‐Derived Models: Advanced Tools for Precision Medicine in Neuroblastoma
10.3389/fonc.2022.1085270 · 2022 · External reference
Exploring High‐Throughput Drug Sensitivity Testing in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids in the Era of Precision Medicine
10.1016/j.ejca.2025.115275 · 2025 · External reference
Therapeutic Targeting of KSP in Preclinical Models of High‐Risk Neuroblastoma
10.1126/scitranslmed.aba4434 · 2020 · External reference
Quantitative Scoring of Differential Drug Sensitivity for Individually Optimized Anticancer Therapies
10.1038/srep05193 · 2014 · External reference
Delineating Functional and Molecular Impact of Ex Vivo Sample Handling in Precision Medicine
10.1038/s41698-024-00528-7 · 2024 · External reference
